相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Novel Plasma Biomarkers Associated With Liver Disease Severity in Adults With Nonalcoholic Fatty Liver Disease
Veeral Ajmera et al.
HEPATOLOGY (2017)
NAFLD and diabetes mellitus
Herbert Tilg et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2017)
The Role of Plasminogen Activator Inhibitor Type-1 in Fibrosis
Panagiotis Flevaris et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2017)
Estimation of serum true collagen type III formation (Pro-C3) levels as a marker of non-alcoholic steatohepatitis in a prospective cohort
D. J. Leeming et al.
JOURNAL OF HEPATOLOGY (2017)
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY GUIDELINES FOR MANAGEMENT OF DYSLIPIDEMIA AND PREVENTION OF CARDIOVASCULAR DISEASE - EXECUTIVE SUMMARY
Paul S. Jellinger et al.
ENDOCRINE PRACTICE (2017)
Fibrogenesis assessed by serological type III collagen formation identifies patients with progressive liver fibrosis and responders to a potential antifibrotic therapy
Morten A. Karsdal et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2016)
Diagnosis and Management of Diabetes: Synopsis of the 2016 American Diabetes Association Standards of Medical Care in Diabetes
James J. Chamberlain et al.
ANNALS OF INTERNAL MEDICINE (2016)
Adiponectin as a target for the treatment of nonalcoholic steatohepatitis with thiazolidinediones: A systematic review
Stergios A. Polyzos et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2016)
Serum YKL-40 as a marker of liver fibrosis in patients with non-alcoholic fatty liver disease
Erina Kumagai et al.
SCIENTIFIC REPORTS (2016)
Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease
Paul Angulo et al.
GASTROENTEROLOGY (2015)
CHI3L1 Is a Liver-Enriched, Noninvasive Biomarker That Can Be Used to Stage and Diagnose Substantial Hepatic Fibrosis
Haijun Huang et al.
OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY (2015)
Markers of Collagen Remodeling Detect Clinically Significant Fibrosis in Chronic Hepatitis C Patients
Mette J. Nielsen et al.
PLOS ONE (2015)
Fibroblast growth factor 21 analogs for treating metabolic disorders
Jun Zhang et al.
FRONTIERS IN ENDOCRINOLOGY (2015)
Plasma Pro-C3 (N-terminal type III collagen propeptide) predicts fibrosis progression in patients with chronic hepatitis C
Mette J. Nielsen et al.
LIVER INTERNATIONAL (2015)
Trends in Prevalence and Control of Diabetes in the United States, 1988-1994 and 1999-2010
Elizabeth Selvin et al.
ANNALS OF INTERNAL MEDICINE (2014)
Molecular Mechanisms and New Treatment Strategies for Non-Alcoholic Steatohepatitis (NASH)
Akinobu Takaki et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2014)
The Effects of LY2405319, an FGF21 Analog, in Obese Human Subjects with Type 2 Diabetes
Gregory Gaich et al.
CELL METABOLISM (2013)
The adipokine adiponectin has potent anti-fibrotic effects mediated via adenosine monophosphate-activated protein kinase: novel target for fibrosis therapy
Feng Fang et al.
ARTHRITIS RESEARCH & THERAPY (2012)
Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults
G. Vernon et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2011)
Adiponectin Regulation of Stellate Cell Activation via PPARγ-Dependent and -Independent Mechanisms
Mahnoush S. Shafiei et al.
AMERICAN JOURNAL OF PATHOLOGY (2011)
Selection of the appropriate method for the assessment of insulin resistance
Anwar Borai et al.
BMC MEDICAL RESEARCH METHODOLOGY (2011)
Serum total adiponectin in nonalcoholic fatty liver disease: a systematic review and meta-analysis
Stergios A. Polyzos et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2011)
The role of adiponectin in the pathogenesis and treatment of non-alcoholic fatty liver disease
Stergios A. Polyzos et al.
DIABETES OBESITY & METABOLISM (2010)
A position statement on NAFLD/NASH based on the EASL 2009 special conference
Vlad Ratziu et al.
JOURNAL OF HEPATOLOGY (2010)
Acute glucose-lowering and insulin-sensitizing action of FGF21 in insulin-resistant mouse models-association with liver and adipose tissue effects
Jing Xu et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2009)
Trends in Cardiovascular Disease Risk Factors in Individuals With and Without Diabetes Mellitus in the Framingham Heart Study
Sarah Rosner Preis et al.
CIRCULATION (2009)
Comparison of Noninvasive Markers of Fibrosis in Patients With Nonalcoholic Fatty Liver Disease
Amy G. Shah et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2009)
Prevalence and associated factors of non-alcoholic fatty liver disease in patients with type-2 diabetes mellitus
Nathalie C. Leite et al.
LIVER INTERNATIONAL (2009)
Fibroblast Growth Factor 21 Corrects Obesity in Mice
Tamer Coskun et al.
ENDOCRINOLOGY (2008)
Plasminogen activator inhibitor-1 and thrombin activatable fibrinolysis inhibitor levels in non-alcoholic steatohepatitis
S. Yener et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2007)
The NAFLD fibrosis score: A noninvasive system that identifies liver fibrosis in patients with NAFLD
Paul Angulo et al.
HEPATOLOGY (2007)
The metabolic state of diabetic monkeys is regulated by fibroblast growth factor-21
Alexei Kharitonenkov et al.
ENDOCRINOLOGY (2007)
The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population
Giorgio Bedogni et al.
BMC GASTROENTEROLOGY (2006)
FGF-21 as a novel metabolic regulator
A Kharitonenkov et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Methods for clinical assessment of insulin sensitivity and β-cell function
G Pacini et al.
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (2003)
The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice
AM Xu et al.
JOURNAL OF CLINICAL INVESTIGATION (2003)
The role of the novel adipocyte-derived hormone adiponectin in human disease
JJ Díez et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2003)
Updated definitions of healthy ranges for serum alanine aminotransferase levels
D Prati et al.
ANNALS OF INTERNAL MEDICINE (2002)
分享论文
